Should you buy Blackmores Limited shares before its trading update?

Are Blackmores Limited (ASX:BKL) shares worth a punt at the current price?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Blackmores Limited (ASX: BKL) shares have been on a rollercoaster since January 2015; starting in the $30s, rising up to $217 by December 2015, now down to $112 today.

A shareholder could be sitting on a 350% gain or 48% loss depending on when they bought the shares. Even with this drop, Blackmores is one of Australia's biggest health companies with a market capitalisation of $1.9 billion.

So why has its share price been so topsy-turvy?

Outstanding results 

In FY14 Blackmores earned $25.4 million in net profit after tax (NPAT), in FY15 its NPAT was $46.5m and in FY16 NPAT was $100m. By my calculations, Blackmores grew its profits by 394% between FY14 and FY16.

Naturally, the market loved this growth and increased the share price with expectations of further great results. Perhaps the market expected too much?

Asia

A large part of Blackmores' growth has been attributed to Asian consumers, officially and unofficially. Demand was so high, Australians were purchasing and shipping the product over to China. In fact, Blackmores estimates that around 50% of its products are sold to Asian consumers.

The Chinese government recently declared they want to limit this grey market of goods arriving unofficially into China. As the market knew this announcement would likely affect Blackmores, its shares were sold down.

Outlook update

In its FY16 release, Blackmores disclosed that it expects the first quarter of FY17 to be down on the prior corresponding period (but didn't disclose how much down). Considering the market had priced in growth, this unexpected news added to the decline.

On the same presentation slide, Blackmores said it was confident that sales will improve as the year progresses. The share price decline may have been too negative if Blackmores resumes growth in the upcoming quarters.

Reasons to be positive about Blackmores

Blackmores acquired 'Global Therapeutics' in May 2016 for $23m. The acquisition has two brands offering Chinese herbal medicine – these brands are market leaders in this category at health food stores and pharmacies.

Blackmores will soon be launching in Indonesia, further expanding its overseas markets.

The partnership with Bega Cheese Ltd (ASX: BGA) to develop nutritional foods including toddler milk is progressing. In FY17 it has plans to start selling these products in markets like China. Its toddler milk will put it in direct competition with Bellamy's Australia Ltd (ASX: BAL).

Blackmores' balance sheet is in an extremely strong position; its gearing ratio is a low 9.1% and its net interest cover is 80.2x.

Dividend

Blackmores' grossed up dividend yield is currently around 5.2%. Considering Blackmores is expected to pay a dividend of $6.20 per share by FY18 (source:Commsec), this suggests Blackmores is trading at a forward yield of 7.9%. This makes Blackmores look like an attractive income and growth stock.

Time to buy?

Blackmores is currently trading at 18.5x FY16's earnings and 13.2x FY18's estimated earnings. These ratios appear reasonable for the potential growth on offer.

As I mentioned before, Blackmores didn't disclose how 'down' the first quarter would be – 1% down and 10% down are both 'down'.

I think Blackmores looks like a good buy at this price, but it may be worth splitting a potential investment in half; invest half before the Q1 update and the other half afterwards, in case a cheaper price is available.

Motley Fool contributor  Tristan Harrison has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »